1. Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy
- Author
-
Mary J. Kasten, Mary J. Burgess, and John D. Zeuli
- Subjects
Gerontology ,Drug ,Population ageing ,Pediatrics ,medicine.medical_specialty ,Epidemiology ,medicine.medical_treatment ,media_common.quotation_subject ,Population ,Dermatology ,Disease ,Review ,Management of HIV/AIDS ,Virology ,medicine ,education ,Depression (differential diagnoses) ,media_common ,Polypharmacy ,aging population ,education.field_of_study ,management issues ,business.industry ,Health Policy ,virus diseases ,HIV ,drug interactions ,Regimen ,Infectious Diseases ,medication adherence ,business - Abstract
Patients with human immunodeficiency virus (HIV) are living longer with their disease, as HIV has become a chronic illness managed with combination antiretroviral therapy (cART). This has led to an increasing number of patients greater than 50 years old living successfully with HIV. As the number of older adults with HIV has increased, there are special considerations for the management of HIV. Older adults with HIV must be monitored for drug side effects and toxicities. Their other non-HIV comorbidities should also be considered when choosing a cART regimen. Older adults with HIV have unique issues related to medication compliance. They are more likely than the younger HIV patients to have vision loss, cognitive impairment, and polypharmacy. They may have lower expectations of their overall health status. Depression and financial concerns, especially if they are on a fixed income, may also contribute to noncompliance in the aging HIV population.
- Published
- 2015